1 Min Read
Nov 8 (Reuters) - Lonza Group AG:
* FDA APPROVES FIRST DRUG USING THE RECOMBINANT FACTOR C ASSAY FOR ENDOTOXIN TESTING Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.